NCT04783012

Brief Summary

Management of postoperative urinary retention often requires the use of indwelling catheters. The purpose of this study is to see if patient removal of catheters at home is non-inferior to standard office removal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2021

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

February 19, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2022

Completed
Last Updated

July 18, 2023

Status Verified

March 1, 2023

Enrollment Period

1.5 years

First QC Date

February 19, 2021

Last Update Submit

July 17, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Risk of Urinary Retention in the Early Postoperative Period

    The percentage of patients who have urinary retention in the early postoperative period (failed voiding trial after discharge POD 2-5) will be measured.

    2-5 days postoperatively

Secondary Outcomes (1)

  • Number of nursing calls and office visits for urinary issues in the six week postoperative period

    6 week postoperative period

Study Arms (2)

Home removal of catheter after surgery

EXPERIMENTAL

Patients randomized to home removal will be assigned to remove their catheters on postoperative day (POD) 2 (or if Th/F surgery, POD 4 or POD 3, respectively). They will be handed an instructional packed with visual, written and video instructions for catheter removal.

Procedure: Catheter removal

Office removal of catheter after surgery

ACTIVE COMPARATOR

Patients randomized to office removal will be assigned to return to the office on POD 2 (or if Th/F surgery, POD 4 or POD 3, respectively) for standard nurse visit with backfill, catheter removal and voiding trial in the office.

Procedure: Catheter removal

Interventions

Catheter management strategy after surgery

Home removal of catheter after surgeryOffice removal of catheter after surgery

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All women undergoing prolapse or anti-incontinence surgery who fail their voiding trials prior to discharge
  • + years old

You may not qualify if:

  • Non-English speaking
  • Pregnant
  • Elevated PVR (\>150 mL) or dependent upon catheterization to void pre-operatively
  • Urethral bulking injection surgery
  • Intra-operative complication requiring prolonged catheterization
  • Unable or unwilling to remove catheter at home

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UNC Hillsborough Hospital

Hillsborough, North Carolina, 27287, United States

Location

UNC Rex Hospital

Raleigh, North Carolina, 27607, United States

Location

Related Publications (1)

  • Askew AL, Margulies SL, Agu I, LeCroy KM, Geller E, Wu JM. Patient Removal of Urinary Catheters After Urogynecologic Surgery: A Randomized Controlled Trial. Obstet Gynecol. 2024 Feb 1;143(2):165-172. doi: 10.1097/AOG.0000000000005454. Epub 2023 Nov 14.

MeSH Terms

Conditions

Patient Satisfaction

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Ijeoma Agu, MD

    UNC Chapel Hill

    PRINCIPAL INVESTIGATOR
  • Jennifer M Wu, MD, MPH

    UNC Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2021

First Posted

March 4, 2021

Study Start

February 15, 2021

Primary Completion

July 30, 2022

Study Completion

September 9, 2022

Last Updated

July 18, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 9 to 36 months following publication
Access Criteria
Obtains approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Locations